Sugi Predict

Sugi Predict / Compounds / SCHEMBL11944271

SCHEMBL11944271

SCHEMBL11944271

CC(C)S(=O)(=O)N1CCN(c2cnn(C3CCCCC3)c(=O)c2OC2CCCC2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCND1 P24385 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ CDK6 Q00534 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ DCTPP1 Q9H773 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ EPHX2 P34913 1/20 0.34
▸ CACNB4 O00305 2/20 0.34
▸ CACNA1A O00555 2/20 0.34
▸ CACNA1G O43497 2/20 0.34
▸ CACNG3 O60359 2/20 0.34
▸ CACNA1F O60840 2/20 0.34
▸ CACNA1H O95180 2/20 0.34
▸ CACNB3 P54284 2/20 0.34
▸ CACNA2D1 P54289 2/20 0.34
▸ CACNG7 P62955 2/20 0.34
▸ CACNA1B Q00975 2/20 0.34
▸ CACNA1D Q01668 2/20 0.34
▸ CACNB1 Q02641 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11944340 0.99 HRH3 (0.35) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944203 0.99 CCND1 (0.35) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944264 0.89 ALDH1A1 (0.43) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944223 0.89 CCND1 (0.33) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944212 0.89 ALDH1A1 (0.43) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944199 0.88 ALDH1A1 (0.44) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944278 0.88 CCND1 (0.33) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11946091 0.86 ATR (0.33) CCND1CCNE1CDK2CDK6ALDH1A1
SCHEMBL11944157 0.84 KDM4E (0.42) CCNE1CDK2ALDH1A1CNR2NAMPT
SCHEMBL11944319 0.83 KDM4E (0.41) CCNE1CDK2ALDH1A1CNR2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA CCND1 3764/4885CCNE1 2368/4885CDK2 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback